Market Tracker

07/28 6:05pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

During the Trading Day
14.54 -0.78 / -5.09%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
14.54 0.00 / 0.00%
 
Volume: 4.1K

Today’s Trading

Previous close15.32
Today’s open15.88
Day’s range13.91 - 16.20
Volume1,412,328
Average volume (3 months)280,613
Market cap$335.6M
Dividend yield--
Data as of 4:00pm ET, 07/28/2014

Growth & Valuation

Earnings growth (last year)-80.56%
Earnings growth (this year)-31.69%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DNDNDendreon Corp-0.05-2.34%
VCYTVeracyte Inc+0.01+0.07%
GERNGeron Corp-0.03-1.24%
OXFDOxford Immunotec Glo...-0.06-0.37%
Data as of 4:00pm ET, 07/28/2014

Financials

Next reporting dateAugust 8, 2014
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$21.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts